Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug trial aims to shrink tumors before surgery for lung cancer patients

NCT ID NCT07489066

Not yet recruiting Disease control Sponsor: Pfizer Source: ClinicalTrials.gov ↗

Summary

This study is testing a new medicine called PF-08634404 to see if it can help adults with early-stage non-small cell lung cancer. The medicine will be given either alone or with chemotherapy, depending on whether the cancer can be removed with surgery. Researchers want to see if the treatment shrinks tumors, helps more people have successful surgery, and prevents the cancer from coming back.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.